title: eLetter: Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors by M Genovese.
authors: Areti
authors: A
authors: Triantafyllou
authors: Athina
authors: A
authors: Pyrpasopoulou
authors: Panagiota
authors: P
authors: Anyfanti
authors: Ekaterini
authors: E
authors: Balaska
authors: Spyros
authors: S
authors: Aslanidis
authors: Stella
authors: S
authors: Douma
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D053264:B-Cell Activating Factor / Q000032:analysis / Q000037:antagonists & inhibitors*; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D053264:B-Cell Activating Factor; D014409:Tumor Necrosis Factor-alpha; C575974:tabalumab